Related Experiment Video
Updated: May 18, 2026

Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
Virus-like particles as universal influenza vaccines
Sang-Moo Kang1, Min-Chul Kim, Richard W Compans
1Center for Inflammation, Immunity & Infection, and Department of Biology, Georgia State University, Atlanta, GA 30303, USA. skang24@gsu.edu
Developing universal influenza vaccines requires presenting conserved viral antigens on virus-like particles (VLPs) with adjuvants. This approach aims to improve immunogenicity against diverse and pandemic influenza strains.
Area of Science:
- Virology and Immunology
- Vaccine Development
Background:
- Current influenza vaccines target strain-specific hemagglutinin, limiting efficacy against novel pandemic strains.
- Need for universal influenza vaccines to provide broad protection against diverse influenza virus subtypes.
Purpose of the Study:
- To review conserved antigenic targets for universal influenza vaccines.
- To explore the use of virus-like particles (VLPs) and molecular adjuvants for enhanced vaccine immunogenicity.
Main Methods:
- Review of literature focusing on conserved influenza antigens and adjuvant strategies.
- Discussion of virus-like particles (VLPs) as platforms for presenting conserved epitopes.
- Analysis of membrane-anchored molecular adjuvants integrated into VLPs.
Main Results:
- Identified conserved antigenic targets including hemagglutinin stalk, M2 ectodomain, and neuraminidase.
- Demonstrated potential of VLPs to present these conserved epitopes in an immunogenic conformation.
- Highlighted the role of molecular adjuvants in enhancing VLP-based vaccine immunogenicity.
Conclusions:
- Virus-like particles (VLPs) combined with molecular adjuvants offer a promising strategy for universal influenza vaccine development.
- Targeting conserved epitopes on VLPs can induce broader and more durable immunity against influenza viruses.
More Related Videos
08:10Production of High-Titer Infectious Influenza Pseudotyped Particles with Envelope Glycoproteins from Highly Pathogenic H5N1 and Avian H7N9 Viruses
Published on: January 15, 2020
05:15Detection of Neutralization-sensitive Epitopes in Antigens Displayed on Virus-Like Particle (VLP)-Based Vaccines Using a Capture Assay
Published on: February 10, 2022
Related Concept Videos
Influenza
Viral Recombination
Leaky Scanning
Vaccinations
Viruses with RNA Genomes
Subviral Agents